News Listing

A recent report from TEConomy highlights New York's growing leadership in the life sciences industry, with bioscience-related R&D expenditures reaching $5.5 billion in FY 2022, significant employment growth, and over $25 billion in venture capital investments over the past five years. Public and private sector initiatives, including policy changes and strategic investments, have positioned New ...

Governor Hochul announces a new State-of-the-Art Cell and Gene Therapy Hub on Long Island, positioning New York as a national leader in innovative medical treatments and fostering economic growth in the life sciences sector.

NewYorkBIO CEO Jennifer Hawks Bland connected with Pharmaceutical Executive for a Q&A focused on life science investor trends, and why New York continues to thrive in the current market, as we continue to witness trends across the industry.

​

FT US PHARMA AND BIOTECH SUMMIT​

May 16, 2024​

In-Person & Digital | Convene at One Liberty Plaza, New York

Composed of accomplished leaders across the life science industry, together they will support innovation.

NewYorkBIO Board Member Annette Bakker's op-ed published in BioSpace discussing nonprofits role in life science innovations.

NewYorkBIO convenes trade leaders from across the country to ring NYSE closing bell and kick off Biotech Month

Legislation signed by Governor Hochul

Join us Tuesday December 5th for another edition of our Virtual Breakfast Series featuring Don Drakeman. Sponsored by Mayer Brown.

NewYorkBIO's CEO, Jennifer Hawks Bland, writes in The Buffalo News.